Opening arguments in the long-awaited trial questioned whether the Theranos chief executive was knowingly deceptive or blindly ambitious.
Source link
Opening arguments in the long-awaited trial questioned whether the Theranos chief executive was knowingly deceptive or blindly ambitious.
Source link